Studies now have confirmed that methionine restriction promoted weight and fat loss and increased energy expenditure while increasing systemic FGF21 in mice with obesity, but also found that FGF21 was dispensable for the weight loss effects (57, 58). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.